Therapeutic Antibody Binding Affinity to CD16a. Dose-response curves were created using a 1:2 dilution scheme, starting at 1.98 μM for IgG1, and 0.83 μM for Cetuximab and 12G5. Cryopreserved cell and Human IgG-d2 Ab concentrations were as previously described.
{}